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Cell culture process development requires the screening of large numbers of cell lines and
process conditions. The development of miniature bioreactor systems has increased the
throughput of such studies; however, there are limitations with their use. One important con-
straint is the limited number of offline samples that can be taken compared to those taken
for monitoring cultures in large-scale bioreactors. The small volume of miniature bioreactor
cultures (15 mL) is incompatible with the large sample volume (600 mL) required for bioa-
nalysers routinely used. Spectroscopy technologies may be used to resolve this limitation.
The purpose of this study was to compare the use of NIR, Raman, and 2D-fluorescence to
measure multiple analytes simultaneously in volumes suitable for daily monitoring of a mini-
ature bioreactor system. A novel design-of-experiment approach is described that utilizes
previously analyzed cell culture supernatant to assess metabolite concentrations under vari-
ous conditions while providing optimal coverage of the desired design space. Multivariate
data analysis techniques were used to develop predictive models. Model performance was
compared to determine which technology is more suitable for this application. 2D-
fluorescence could more accurately measure ammonium concentration (RMSECV
0.031 g L21) than Raman and NIR. Raman spectroscopy, however, was more robust at mea-
suring lactate and glucose concentrations (RMSECV 1.11 and 0.92 g L
21, respectively) than
the other two techniques. The findings suggest that Raman spectroscopy is more suited for
this application than NIR and 2D-fluorescence. The implementation of Raman spectroscopy
increases at-line measuring capabilities, enabling daily monitoring of key cell culture com-
ponents within miniature bioreactor cultures. VC 2017 American Institute of Chemical Engi-
neers Biotechnol. Prog., 33:337–346, 2017
Keywords: Raman spectroscopy, near-infrared spectroscopy, 2D-fluorescence, process ana-
lytical technology (PAT), design of experiments
Introduction
The industry in recent years has become increasingly
interested in the use of spectroscopy technologies such as
Raman, near-infrared (NIR), and 2D-fluorescence (2D-F) for
the measuring, monitoring, and control of bioprocesses. This
is, in part, a result of the American Food and Drug Adminis-
tration’s (FDA) guidance on process analytical technology
(PAT), which encourages the use of innovative tools and
technologies to increase understanding and control of
manufacturing processes.1 Since the publication of this work,
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there has been an increasing move to develop biopharmaceu-
tical processes using a Quality by Design (QbD) approach.
The ICH Q8 guideline defines QbD as “a systematic
approach to development that begins with predefined objec-
tives and emphasizes product and process understanding and
process control, based on sound science and quality risk
management.”2 Spectroscopy technologies offer a nonde-
structive, rapid, and robust method for generating multiana-
lyte data.3 These technologies are used routinely to monitor
chemical pharmaceutical production processes, but their
application to mammalian cell culture for production of bio-
logics is much more challenging. This is primarily due to
the complex matrix background4 and low concentrations of
the metabolites of interest. Despite these challenges, there is
a growing body of literature demonstrating their ability to
measure multiple analytes simultaneously, such as glucose,
ammonium, and lactate in mammalian cell culture.5–10 The
primary focus, however, has been on their use for online
monitoring at laboratory scale (e.g., 5–10 L). The applicabil-
ity of spectroscopic methods for miniature bioreactor (MB)
cultures has been reviewed11; however, the authors are not
aware of any literature experimentally comparing the ability
of spectroscopy techniques to monitor multiple analytes
under suitable operational constraints required for daily mon-
itoring of MB cultures.
MB are widely utilized in the development of biologics.
Cell culture process development requires the screening of
large numbers of cell lines. Traditionally, this has been car-
ried out using shaken flask cultures with successful cell lines
progressing to bench-top bioreactors and on to pilot-scale
studies.12 Shaken flask cultures are used due to their ease of
operation with few mechanical complications12 coupled with
low costs. There are, however, limitations with shaken flask
cultures, including gas transfer and continuous monitoring.13
In response to these limitations, considerable effort has been
invested in the development of MB systems that can better
model the physiochemical environment experienced by cells
in laboratory-scale bioreactor cultures.
The ambrTM system (Sartorius Stedim) is a commercially
available MB system that mimics many of the characteristics
of laboratory-scale bioreactors. Each vessel has an internal
impeller, closed loop control for pH and dO2 and indepen-
dent control of O2 and CO2 gas flow rates. Several studies
have been carried out demonstrating that culture performance
in laboratory-scale, stirred-tank bioreactors is more compara-
ble to that in MBs than in traditional shaken flask cul-
tures14,15 and that process and product characteristics of
MBs are comparable to laboratory-scale.16 There are still,
however, a number of limitations including lack of geometric
similarity with large-scale vessels12 and desirable operational
controls, for example, continuous feeding.15 pH, temperature,
and dO2 are measured online for the MB system. In current
laboratory-scale bioreactors, however, additional analytes are
often measured to improve control of the nutritional environ-
ment and facilitate process improvement. For example, glu-
cose, lactate, and ammonium are routinely measured by
taking offline measurements with bioanalysers such as Nova
BioProfile 400 (Nova Biomedical). The small volume of MB
cultures (15 mL) is, however, incompatible with the large
sample volume required for this analyser (600 mL), prevent-
ing daily offline samples.11 Moreover, it would take
approximately 3 h to analyze all 48 vessels of a typical MB
system. This constraint results in a tradeoff between data
quantity and experimental throughput,12 and spectroscopy
technologies may be used to resolve this constraint. This
study compares the ability of NIR, Raman, and 2D-F for
measuring analytes in cell culture supernatant under con-
straints imposed by MB cultures to allow daily monitoring:
1. Analytes must be measured for all 48 MB vessels within
1 h
2. Sample volume must be <50 mL
These constraints are specific to MB systems. Large-scale
bioreactors often implement a continuous feeding strategy
for glucose. This cannot be performed for current MB sys-
tems. To mimic the feeding strategy at larger scale, glucose
is fed every 8 h. A control feedback loop is used to alter the
glucose feed rate as a function of the glucose concentration
and the volume of cell culture currently within the vessel.
To minimize the time between taking an offline measure-
ment and feeding glucose, all results must be obtained within
1 h. As such, the total acquisition times were minimized to
meet the time constraint required of the current feeding strat-
egy. The working volume of each vessel is 10–15 mL.
Excessive removal of the culture throughout the process will
lower the working volume below this range, changing the
culture conditions. This can lead to detrimental effects on
culture performance as lower volumes will increase oxygen
uptake causing aberrant foaming and lack of DO control. As
a result, culture removal needs to be minimized. Small sam-
ple sizes of <50 mL must therefore be used to reduce the
amount of culture being removed from each vessel to allow
daily offline monitoring of MB cultures.
A design-of-experiment (DOE) approach was used to
select from a library of cell culture supernatant samples.
Spectra were acquired by the 3 spectroscopy technologies
for each sample under the operational constraints required
for daily monitoring of a MB system. A range of multivari-
ate data analysis (MVDA) and data handling techniques
were investigated to develop predictive models for each ana-
lyte, including partial least squares (PLS), unfolded-PLS,17
multiway PLS (NPLS18), and parallel factor analysis (PAR-
AFAC). The performance of each model was compared to
determine which spectroscopy technology would be more
suitable for measuring the 3 analytes.
Materials and Methods
Experimental design
Three analytes were considered in this investigation: glu-
cose, lactate, and ammonium. The design space of these 3
analytes was defined by the range in concentration observed
in good physical scale-down models, operated at 10 L scale,
of cGMP production bioreactors; 0–10, 0–15, and 0–0.3
gL21, respectively. A library of historical cell culture super-
natant samples was compiled (957 samples) covering this
design space for the 3 analytes. The library consisted of his-
torical cell culture supernatant samples taken from a range
of fed-batch cultures using different GS-CHO cell lines
(Lonza Biologics, UK). It included samples from approxi-
mately 18 different cell lines grown under many different
medium and feed conditions to span as much of the design
space as possible. Metabolite data from the library were
compiled based on historical values determined using a
Nova BioProfile 400 (Nova Biomedical). Design Expert
VR
was used to select samples from the library using the histori-
cal metabolite information. An IV-optimal algorithm was
used such that the design space was best represented given
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the number of samples to be tested (discussed later). Twenty
cell culture supernatant samples were selected from the
library to assess each spectroscopy technology.
Spectroscopy techniques
FT-NIR Spectroscopy. A plastic, disposable 96-well plate
(Greiner Bio-One) was used to hold 20 mL of cell culture
supernatant. Each sample was tested in triplicate. Fourier-
Transform NIR (FT-NIR) spectra were recorded using optic
fibers connected to an ABB Bomem FT-NIR spectrophotom-
eter (MB series). Transmission sampling was carried out by
positioning the emitting optic fiber below the plate and col-
lecting by another fiber above the plate using an experimen-
tal setup. Spectra acquisition was performed in the range
4000–10,000 cm21 with a 4 cm21 resolution. Sixty-four
scans were taken, resulting in each well taking a total of 1
min 29 s to measure. A background spectrum was measured
at the start of each plate by collecting the spectrum of an
empty well. The plate was manually positioned to ensure the
optic fibers were centered below and above each well at the
time of measurement.
Raman Spectroscopy. A plastic, disposable 96-well plate
(NuncTM) was used. Automated plate positioning was carried
out. Raman spectra were collected with a 785 nm excitation
laser using the Raman WorkStationTM microscope (Kaiser
Optical Systems). The laser power was 400 mW at the
source resulting in 100 mW at the sample. An objective
with 103 magnification was used and focused with a stan-
dard of 20 mL ethanol. Twenty microliters of cell culture
supernatant was then analyzed in triplicate. An exposure
time of 10 s by 2 scans was used and co-added to give a
total exposure time of 20 s per spectral sample acquisition.
Cosmic ray interference removal was applied,19,20 resulting
in a total processing time of 40 s per sample. Spectra were
collected at 0.3 cm21 resolution between 0 and 1900 cm21.
2D-Fluorescence Spectroscopy. A plastic, disposable 96-
well plate (Greiner Bio-One) was used to hold 20 mL of cell
culture supernatant. Each sample was tested in triplicate.
Excitation-emission matrices (EEMs) were recorded using an
at-line multichannel fluorescence detection system (BioView,
Delta Light and Optics, Denmark). Excitation filters ranging
from 270 to 550 nm and emission filters ranging from 310 to
590 nm were used, with a filter step-size of 20 nm for both
directions. The plate was manually positioned to ensure the
probe was placed directly above the sample.
Model development
MVDA techniques were used to develop predictive models
for glucose, lactate, and ammonium concentration in cell cul-
ture supernatant. Spectra of all 3 sample replicates were used
for model development (N5 60). PLS was applied to develop
predictive models using the spectra collected by the FT-NIR
and Raman spectrophotometers. EEMs have increased modes
as they incorporate excitation wavelength, emission wave-
length, and fluorescence intensity,21 resulting in a 3-
dimentional (3D) dataset structure. The analysis of this type
of data structure is more complex than that obtained from
Raman or NIR spectroscopy. Similar chemometric techniques
can, however, be used to decompose the 3D multivariate data
such as unfolded-PLS, NPLS, and PARAFAC (discussed lat-
er). Historical metabolite data generated using the Nova Bio-
Profile 400 were used for the calibration of all models
developed. The imprecision resolution for each analyte was
5% as reported by the vendor over a range of 0.2–15.0 gL21,
0.2–5.0 gL21, and 0.2–25.0 mmol.L21 for glucose, lactate,
and ammonium, respectively.22 Internal cross-validation was
applied to determine a level of model robustness. Owing to
the small sample size, a “Venetian blinds” approach (Eigen-
vector Research Inc, 2013) was used. Model performance was
determined by calculating the root mean square error (RMSE)
of calibration (RMSEC) and cross-validation (RMSECV).
These performance indicators are used routinely to determine
the difference between model predictions and measurement
values (Eq. 1)
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where ymodel,i are the values predicted by the model
(RMSEC) or cross-validation resampling strategy (RMSECV),
and yref,i are the values obtained from the reference method.
Outliers were identified by high Hotelling’s T2 and Q residu-
al values (data not shown). The PLS_Toolbox (Eigenvector
Research, Inc.) and the N-way toolbox in Matlab24 were
used for analysis and model development.
Results and Discussion
Design of experiments
Biopharmaceutical process development is moving toward
working under a QbD paradigm. QbD involves many steps as
defined in the literature,25 but one primary difference to tradi-
tional manufacturing is defining a process design space. A
design space can be defined as “the multidimensional combina-
tion and interaction of input variables (e.g., material attributes)
and process parameters that have been demonstrated to provide
assurance of quality.”26 Working within a design space allows
greater flexibility but requires a greater understanding of the
process. It is extremely important for models to be calibrated
using samples that are representative of this design space, to
ensure model robustness to variability usually experienced by
the process. The investigation presented in this article defined
the design space (i.e., the range of concentration) of the 3 ana-
lytes according to ranges in concentrations observed in good
physical scale-down models, operated at 10 L scale, of cGMP
production bioreactors. Obtaining nonartificial samples span-
ning the design space is time-consuming and costly. MB sys-
tems have the ability to conduct a large number of controlled,
parallel experiments while monitoring several process varia-
bles,27 which is useful for testing many conditions; however,
the same operational constraints are faced with respect to
removing samples. Bioanalysers routinely used require a large
sample volume, limiting the number of offline measurements
that can be taken. Obtaining reference data required for model
development is therefore extremely challenging. The methodol-
ogy presented here utilized samples generated from historical
experiments to reduce the time and complexity of obtaining
representative samples and enabled reference data already gen-
erated to be used for model development.
The literature demonstrates that MB cultures are compara-
ble to those at larger scale.16 As a result, it was not impor-
tant to use samples taken from MB cultures. A library of
historical samples for which historical metabolite data was
available, was collated that incorporated cell culture superna-
tant sampled from a range of scales, primarily 10 L cultiva-
tions. Spectra of these samples were then acquired under the
constraints required for daily monitoring of an MB system.
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Figures 1A–C show the analyte concentration distribution
of the full library (957 samples) in the selected design space.
It can be seen that the samples did not cover the entire
design space. In particular, a large area where both ammoni-
um and glucose concentrations are high is not well repre-
sented. Subsequent models developed will therefore not
capture this behavior and potentially will not be able to
accurately predict concentrations within this area of the
design space. The library demonstrates, however, that these
concentrations are unlikely to be observed during the stan-
dard growth cycle of CHO cells, and the omission could
therefore be considered physiologically irrelevant from a bio-
processing perspective. As a result, this is not considered a
true limitation of the design space, but it might nevertheless
limit the capabilities of the MVDA models.
MVDA techniques, such as PLS, were used for model devel-
opment. These models attempt to describe the largest sources
of variation in the dataset. The source of the largest variations
within the data set is determined by both the particular form of
variation exhibited and the number of samples exhibiting that
form of variation. Figures 1A–C display data typical for fed-
batch bioprocesses with the vast majority of the behavior cap-
tured by the data being concentrated in a very small part of the
design space. This will be reflected in subsequent MVDA mod-
els. Samples in unusual outlying parts of the design space are
likely to be poorly described by the model (and will appear as
outliers having high residuals). For this reason, the authors
chose to select a much smaller subset representative of the
design space rather than samples representative of the sample
library, to develop a robust model able to cope with all the
conditions likely to arise. A DOE approach was therefore used
to select a subset representative of the design space from the
library of historical samples. There are a number of characteris-
tics that should be considered to generate a good experimental
design, including, cost effectiveness (i.e., does not require too
many runs/samples) and providing a good distribution of the
variance of the predicted response throughout the design
region.28 Ideally, the design should have a low and flat/homolo-
gous prediction variance across the design space.28,29 Samples
were therefore selected from the library by point exchange to
satisfy an IV optimality criterion. An IV-optimal design calcu-
lates and minimizes the average or integrated prediction vari-
ance over the design space30 (Equation 2):
IV5
1
A
ð
R
V ypred xð Þ dx
where R is the design region, A is the volume of the region,
V is the variance, x are the candidate points, and ypred is the
prediction response. A subset of samples representative of
the design space was selected from the original library (Fig-
ures 2D–F). A subset of 20 samples was selected from the
library to enable a fast, efficient approach for comparing the
three technologies, which were not all high throughput in the
available format.
Figure 1. Design space of sample library: glucose (A), lactate (B), and ammonium (C) concentrations of the entire sample library
(N5 957). (D), (E), and (F) show the subset of the library selected using the DOE approach (N5 20).
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Model development
One of the main challenges of using IR to measure analy-
tes in cell culture is its sensitivity to water. NIR spectra
obtained primarily represented the first overtone of the OAH
stretch in water with a single peak at 1400–1500 nm. Its
high signal can mask other information in the spectrum.
Removing this water peak decreased the model RMSECV
for the lactate concentration model from 2.76 gL21 to
2.33 gL21 and increased the variance captured by the model
from 78.46% to 86.80%. Water peak removal improved
model performance for all other models developed using
NIR spectra. Other preprocessing techniques, for example,
baseline correction and standard normal variate20 that
resulted in the best-performing predictive models, were
applied after water peak removal. The raw spectra and one
example of preprocessed spectra used for model develop-
ment are provided in the Supporting Information.
Raman spectroscopy is less sensitive to water interference,
and this is advantageous when measuring analytes in cell
cultures. However, fluorescence interference can occur as
fluorescence has a much stronger signal then Raman
scattering,31 causing the spectra baseline to shift.32 This can
be reduced by increasing the wavelength of the laser
source33 but interference can still occur. Derivative filters
and polynomial background fitting can be applied to correct
for fluorescence.32 Preprocessing methods were applied that
resulted in the best-performing predictive models. Raw
Raman spectra and one example of preprocessed spectra
used for model development are provided in the Supporting
Information.
Fluorescence EEMs also require preprocessing, as both
Raman and Rayleigh scattering can cause interference and
bias the estimated model parameters.34 This is particularly
important when using PARAFAC to analyse the data. PAR-
AFAC decomposes the fluorescence signal into a number of
trilinear structures. Rayleigh and Raman peaks do not follow
trilinearly, as, for example, the shape and position of the
peaks changes with excitation wavelength.35 Discarding
these peaks and replacing with zeros can remove this signal
interference while still maintaining some chemical and phys-
ical information.36 This method was applied prior to model
development.
Figure 2. Measured versus predicted plots for individual PLS models: (A) lactate by NIR, (B) lactate by Raman, (C) glucose by NIR,
(D) glucose by Raman, (E) ammonium by NIR, (F) ammonium by Raman. Markers indicate replicate measurements from
one sample; solid ellipse identifies sample 1 and dotted ellipse sample 2 (N5 60 for Raman models and N5 59 for NIR mod-
els). Solid black line: line of best fit (R2CV).
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NIR and Raman Predictive Models. Individual PLS mod-
els were developed to predict lactate, glucose, and ammoni-
um concentration in cell culture supernatant samples using
the preprocessed NIR spectra and Raman spectra. Models
developed from Raman spectra used the fingerprint region of
the spectrum (400–1800 cm21). The optimal number of
latent variables (LVs) to include in each model was deter-
mined by comparing RMSECV and RMSEC values to prevent
overfitting.23 Figure 2 displays the measured versus predicted
plots of the PLS models developed for lactate concentration
in cell culture supernatant using NIR spectra (A) and Raman
spectra (B), glucose concentration using the NIR spectra (C)
and Raman spectra (D), and ammonium concentration using
the NIR spectra (E) and Raman spectra (F).
The investigation identified 2 cell culture supernatant sam-
ples whose values were inaccurately predicted by the models
developed using the NIR and Raman technologies (samples
denoted 1 and 2). Both NIR (Figure 2A) and Raman (Figure
2B) predict the lactate concentration in sample 1 (ellipse) to
be 9–10 gL21 instead of 4 gL21 as measured by the
reference method (Nova BioProfile 400). The glucose and
ammonium measurements of this sample were, however,
accurately predicted (purple crosses in Figures 2C–F). Simi-
larly, both technologies were unable to accurately estimate
glucose concentration in sample 2, predicting the value to be
3 gL21 instead of 10 gL21 (identified in Figures 2C and D).
To evaluate the capabilities of both technologies further, the
accuracy and precision of the predictions for these two deviating
samples was examined (Table 1). The RMSECV was used as a
measure of accuracy of the model to predict each sample. The
median absolute deviation (MAD) was calculated as a measure
of the precision37 (Equation 3)
MAD5 Median jYi2Y  jð Þ
where Y is the median of the data and |Y| is the absolute
value. Despite relatively high RMSECV values, both the NIR
and Raman predicted similar concentrations for the analytes
and with relatively good precision. Owing to the close agree-
ment between technologies with regards to the predicted
metabolite concentration and the lack of error in the models
developed to measure ammonium concentration, it was
hypothesized that errors exist within the historical metabolite
concentration data for these two samples. Concentrations of
the 3 analytes were therefore redetermined using the refer-
ence method. New measurements of sample 2 identified
errors with the historical data; historical lactate concentration
was 0 gL21, whereas the new reading measured 1.21 gL21;
and the historical glucose concentration was 10.31 gL21,
whereas the new reading measured 3.16 g L21. This repeated
reference analysis could not be carried out for sample 1 due
to insufficient volume available. New models were devel-
oped using the new measurement of sample 2 and removing
the concentrations determined for sample 1 from the dataset
(Figure 3). This improved the model performance as deter-
mined by RMSECV values.
For indirect statistical models such as PLS, the error of each
model is a combination of the error in the reference method
and the spectroscopy analysis signal. The methodology pre-
sented in this article utilized historical samples to reduce the
time and complexity of obtaining non-artificial samples span-
ning the process design space. Confidence in the accuracy of
Table 1. Precision and Accuracy of the Raman and NIR Predicted
Values for Lactate and Glucose Concentration in Sample 1 and 2.
Sample Technology Analyte Figure
Precision
(gL21)
Accuracy
(gL21)
1 NIR Lactate 2A 1.78 4.92
1 Raman Lactate 2B 0.36 5.63
2 NIR Glucose 2C 0.78 7.59
2 Raman Glucose 2D 0.52 5.09
Figure 3. Measured versus predicted plots for the final PLS models developed: (A) lactate by NIR, (B) lactate by Raman, (C) glucose
by NIR, and (D) glucose by Raman. Dotted ellipse identify sample 2 (N5 57 for Raman models, N5 56 for NIR models).
Solid black line: line of best fit (R2CV).
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the historical data is therefore important to the overall error of
the models developed. This investigation highlights the impor-
tance of reference method accuracy and having confidence in
historical data. In addition, both NIR and Raman spectroscopy
technologies were able to identify these outliers in the histori-
cal data despite model calibration incorporating these errors.
This further highlights the ability of both of these technologies
to measure each of the analytes. The new values were used for
model development with 2D-F EEMs.
2D-Fluorescence Predictive Models. 2D-F produces a
3D dataset by stacking EEMs from different samples. There
are a number of different methods to analyze EEMs. One
method routinely used to analyze fluorescence data involves
unfolding the 3D-dataset as described by Nomikos and Mac-
Gregor (1994) for batch process data.17 The dataset is
unfolded from an I 3 J 3 K cube into a new matrix of size
I 3 JK so standard PLS can be used with the new X dataset.
There are a number of examples where an unfolding
approach has been carried out on 2D-F EEMs,38–40 but it has
been argued that unfolding the dataset loses additional infor-
mation gained from the 3D structure. Other analysis techni-
ques referred to as multiway analyses have been applied to
fluorescence data, specifically NPLS21 and PARAFAC.
NPLS is very similar to PLS; however, the multidimensional
structure is maintained by decomposing the multiway X into,
for example, a set of triads consisting of one score vector
and two weight vectors. PARAFAC is a trilinear unsuper-
vised decomposition method often used for exploratory anal-
ysis. It decomposes the dataset into trilinear components,
resulting in two loading matrices and one scores or
concentration-related matrix. PARAFAC is not a regression
method; however, it has been shown that PLS can be carried
out on PARAFAC scores to develop predictive models.41 All
3 analysis techniques were compared in this investigation.
Determination of the number of components to include in
the NPLS and PLS models was carried out as per the NIR
and Raman spectra. Different methods were used for the
PARAFAC models: core consistency and split-half analy-
sis.42 For the core consistency diagnostic method, 5 individu-
al PARAFAC models were developed, containing from 1 to
5 components using the N-way toolbox in Matlab.24 The
core consistency shows the difference between the core array
of a PARAFAC model compared to the “ideal.” If the core
array is equal to the “ideal,” then the score is 100%. The
results demonstrate that 3 components should be included
(Figure 4). However, core consistency is not always a con-
clusive procedure. Split-half analysis was also performed.
This method involves splitting the dataset into 2 (or more)
sections and developing individual PARAFAC models on
each. If the correct number of components has been included
in the model then, due to the uniqueness property of the
PARAFAC decomposition, the same loadings will be found
for each separate model built on the subsections.43 This test
was performed on the EEMs, where the data were split into
2 subsections, avoiding blocking issues due to the repeated
measurements. Two PARAFAC models were developed on
each subsection, 3 and 4 component models. Unlike the core
consistency analysis, no difference was observed between
subsections for the 3 component model (99.9% similarity) or
the 4 component model (98.9% similarity). Two PLS models
were therefore evaluated; one using scores from the 3 and
one from the 4 component PARAFAC models (Table 2).
Unfolding-PLS and the NPLS methods developed more
accurate models for estimating the concentrations of the 3 ana-
lytes than applying PLS on PARAFAC scores. These findings
agree with those of Mortensen and Bro (2006). PARAFAC is
an unsupervised decomposition method that provides the most
chemically relevant information but not necessarily the most
optimal solutions for predictions.41 PLS and NPLS are calibra-
tion methods that result in a least-squares solution to obtain
maximal covariance between X and Y18 explaining their abili-
ty to develop more accurate predictive models than the unsu-
pervised PARAFAC method. Overall, the unfolding-PLS
method produced better or similar results in predicting lactate,
glucose, and ammonium concentration in 20 mL cell culture
supernatant (RMSECV: 1.06, 1.53, and 0.031 gL21, respec-
tively) (Figures 5A–C). This suggests that maintaining the 3D-
structure of the dataset is not necessary to obtain sufficient
Figure 4. Core consistency calculated for 5 individual PAR-
AFAC models of increasing model complexity.
Table 2. Comparison of Models Developed with the Fluorescence EEM Using Three Different Model Building Techniques: Unfolded-PLS,
NPLS, and PARAFAC-PLS.
Model building method Latent variables RMSEC (gL21) RMSECV (gL21) R2C R2CV
Lactate concentration
Unfolded PLS 9 0.65 1.06 0.975 0.935
NPLS 6 1.81 2.01 0.808 0.770
PARAFAC 3 component/PLS 3 2.82 2.91 0.533 0.502
PARAFAC 4 component/PLS 4 2.80 2.95 0.538 0.490
Glucose concentration
Unfolded PLS 4 1.36 1.53 0.560 0.442
NPLS 5 1.34 1.43 0.572 0.513
PARAFAC 3 component/PLS 2 1.86 1.91 0.166 0.130
PARAFAC 4 components/PLS 4 1.80 1.92 0.220 0.133
Ammonium concentration
Unfolded PLS 9 0.021 0.031 0.960 0.917
NPLS 6 0.041 0.054 0.850 0.748
PARAFAC 3 component/PLS 3 0.084 0.086 0.367 0.342
PARAFAC 4 components/PLS 3 0.082 0.084 0.391 0.363
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information for predicting the 3 analytes in cell culture super-
natant. It is interesting to note that the models developed using
unfolded-PLS required more LVs compared to NPLS to model
the behavior of the samples. This could be a result of losing
the overall 3D-structure.
Comparison of technologies
The aim of this study was to determine which of the 3
spectroscopy technologies could more accurately measure
the concentration of 3 analytes under set criteria, small sam-
ple volume and minimal acquisition times.
For routine operation of the NIR and 2D-F spectrophotom-
eters, a dedicated plate reader would need to be attached to
allow for automated spectra acquisition in each well. Further
studies are therefore required to test any potential reduction
in sensitivity resulting from the application of the automated
technology. The optimized predictive models of each analyte
developed in this investigation were however compared. The
RMSEC/CV and R
2 coefficient were calculated for each mod-
el using an internal cross-validation approach as carried out
in the literature.4,44 In addition, precision was also calculat-
ed. These were used to assess the performance of each mod-
el and compare the technologies (Table 3). Raman and 2D-F
could measure lactate concentration to within a similar accu-
racy (RMSECV 1.11 gL21 and 1.06 gL21, respectively) and
outperformed NIR (RMSECV 2.33 gL21). The lactate model
developed using the Raman spectra, however, demonstrated
better precision compared to that using the fluorescence
EEMs (MAD 0.29 gL21 and 0.43 gL21, respectively).
Raman spectroscopy was considerably more accurate at
measuring glucose concentration (RMSECV 0.92 gL21)
compared to both 2D-F and NIR (RMSECV 1.53 gL21 and
1.50 gL21, respectively) and still demonstrated a good level
of precision (0.31 gL21). NIR demonstrated good precision
(0.012 gL21) for predicting ammonium concentration; how-
ever, the model had a much higher RMSECV and the R
2
coefficient demonstrated the predictions had a much weaker
linear correlation to the measured values (R2CV 0.218). 2D-F
achieved a higher accuracy than both the other methods
for measuring ammonium concentration with an RMSECV
0.031 gL21 compared to RMSECV values of 0.072 gL21
and 0.093 gL21 demonstrated by the models developed
using Raman and NIR spectra, respectively.
Comparison of the performance indicators of the PLS
models developed suggest that Raman or 2D-F would be the
most suitable technology for measuring glucose, lactate, and
ammonium under operational conditions suitable for daily
monitoring of a MB system. The intensity of Raman scatter-
ing is dependent on numerous factors, including the polariz-
ability of the molecule and the concentration of the analyte.
The models developed using Raman spectra may have a
higher error for measuring ammonium concentration com-
pared to 2D-F for this specific application as a result of the
low concentrations being measured and the low polarizability
of the molecule compared to glucose and lactate (glucose:
15.16 A˚3, lactate: 7.43 A˚3, ammonia: 2.26 A˚3).45 2D-F has a
greater sensitivity than both Raman and NIR spectroscopy,46
making the technology more adapt to measuring low analyte
concentrations. 2D-F can, however, only detect molecules
with intrinsic fluorescence properties. The ability of a mole-
cule to fluoresce is related to the extent of conjugation with-
in the molecule as a result of weaker p-bonds. The less
strongly bound electrons can be excited by photons with
lower energy.47 As a result, aromatic and unsaturated com-
pounds are more likely to absorb in the UV–vis region.
Despite this, a number of examples in the literature demon-
strate the ability to develop PLS models using 2D-F EEMs
to predict the concentration of glucose, lactate, and ammoni-
um.9,10 These models, however, rely on correlations with
other factors such as fluorophores involved in cell growth
and glucose consumption.10 Models developed on indirect
measurements are susceptible to metabolic and process
parameter changes.7 As a result, models developed using
2D-F EEMs for this application are highly dependent on the
matrix background and cell lines and may demonstrate little
robustness to process changes.
Figure 5. Measured versus predicted plots for the unfolded
PLS models developed using 2D-fluorescence EEMs:
(A) lactate, (B) glucose, and (C) ammonium concen-
trations (N5 56). Solid black line: line of best fit
(R2CV).
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MVDA was used in this investigation for developing indi-
vidual predictive models measuring lactate, glucose, and
ammonium concentration. Decomposition methods such as
PLS reduce the number of variables to a smaller set of
uncorrelated LVs that explain co-variance with the reference
values and the variance in the spectra. Highly complex mod-
els were developed for the majority of analytes as a result of
the large number of LVs included. The requirement for a
large number of LVs may have been a result of our calibra-
tion approach, which deliberately broke the correlations
between the variables.
Overall, the model errors reported in this investigation are
higher than those published in the literature. However, the lit-
erature primarily demonstrates examples where spectroscopy
technologies are implemented online and whose applications
can allow longer acquisition times, for example, 600 s.48 The
application presented in this investigation requires the results
of all 48 MBs to be obtained in 1 h. As such, this application
is very challenging. Small acquisition times reduce the signal-
to-noise ratio of spectra and will therefore affect the perfor-
mance of subsequent models developed.
Conclusion
A novel approach using DOE methodology was described
that utilized historical cell culture supernatant. The use of
historical samples reduced the time and complexity of an
experiment required to obtain a nonartificial diverse sample
set that also spanned the relevant design space. This study
did, however, demonstrate the importance of having confi-
dence in the historical measurements to develop accurate
predictive models. Further work is required to improve the
predictive capability of the selected technology for accurate
monitoring and control of the process. However, this meth-
odology enabled a quick and effective approach for the tech-
nologies to be compared with samples representative of the
design space. In addition, operational constraints specific to
MB systems were established, in particular the small volume
size and short acquisition times. The experimental compari-
son demonstrated that either 2D-F or Raman spectroscopy
could more accurately measure lactate, glucose, and ammo-
nium concentration in cell culture supernatant for this appli-
cation, than NIR. The data analysis for the 2D-F EEMs was,
however, much more involved than the Raman spectra and
the final models may not be as robust to process changes
due to the reliance on correlations with other components.
This study therefore identified Raman spectroscopy to be the
most suitable technology, at present, for this application. The
implementation of Raman spectroscopy would enable daily
monitoring of key cell culture components, increasing poten-
tial applications for MB systems.
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